Previous studies on hnRNPU in cancer have primarily focused on its proliferative properties in breast cancer [12], hepatocellular carcinoma [14], multiple myeloma [13], and bladder cancer [40]. The gene discussed is HNRNPU; the disease is plasma cell myeloma.